PartsTable
Technical Data Sheet
Download PDF

NDC25021-0301-68 — ADENOSINE INJECTION

✓ Government record, cited
— · COMPONENT
PRODUCT OVERVIEW

NDC25021-0301-68: ADENOSINE INJECTION.

The ADENOSINE INJECTION is a the manufacturer industrial component. Key specifications include primary_container_type: SYRINGE, protective_storage_feature: CONTROLLED ROOM TEMPERATURE AND DO NOT REFRIGERATE, pharmaceutical_vehicle_type: AQUEOUS, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, total_primary_container_quantity: 10, primary_container_content_quantity: 4.0 MILLILITERS. This part is cataloged in the U.S.

Government catalog under NSN 6505-01-666-0343, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.

Verify compatibility with your specific system configuration before ordering.

WHERE IT FITS
NDC25021-0301-68
NSN: 6505-01-666-0343
FSC: 6505 — Drugs and Biologicals
CAGE: 4RP13 — SAGENT PHARMACEUTICALS, INC DBA SAGENT PHARMACEUTICALS, INC (USA)
SPECIFICATIONS
primary_container_typeSYRINGE
protective_storage_featureCONTROLLED ROOM TEMPERATURE AND DO NOT REFRIGERATE
pharmaceutical_vehicle_typeAQUEOUS
medical_designation_and_gradeUNITED STATES PHARMACOPEIA
total_primary_container_quantity10
primary_container_content_quantity4.0 MILLILITERS
active_medicament_medicinal_strength3.0 MILLIGRAMS ADENOSINE ACTIVE INGREDIENT
part_name_assigned_by_controlling_agencyADENOSINE 12 MG, 4 ML SYRINGE, 10S
NSN6505-01-666-0343
COMPONENT DIAGRAM
COMPONENT MAIN IC EDGE CONNECTOR No detailed specs available ADENOSINE INJECTION TITLE COMPONENT PN NDC25021-0301-68 MFR ADENOSINE INJECTION
KEY FEATURES
•
PRIMARY CONTAINER CONTENT QUANTITY: 4.0 MILLILITERS
•
MEDICAL DESIGNATION AND GRADE: UNITED STATES PHARMACOPEIA
•
PRIMARY CONTAINER TYPE: SYRINGE
•
PROTECTIVE STORAGE FEATURE: CONTROLLED ROOM TEMPERATURE AND DO NOT REFRIGERATE
•
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
•
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 3.0 MILLIGRAMS ADENOSINE ACTIVE INGREDIENT
TECHNICAL CHARACTERISTICS
PRIMARY CONTAINER CONTENT QUANTITY4.0 MILLILITERS
MEDICAL DESIGNATION AND GRADEUNITED STATES PHARMACOPEIA
PRIMARY CONTAINER TYPESYRINGE
SPECIAL FEATURES3MG/ML ACTIVE INGREDIENT ADENOSINE 4ML PREFILLED SYRINGE; PRESERVATIVE FREE; (12MG/4ML)PG 10'S NEEDLELESS; STORE AT USP CONTROLLED ROOM TEMPERATURE 20 TO 25 DEG C(68 TO 77 DEG F), DO NOT REFRIGERATE; DO NOT FREEZE; FOR RAPID BOLUS INTRAVENOUS USE. DEGC
PROTECTIVE STORAGE FEATURECONTROLLED ROOM TEMPERATURE AND DO NOT REFRIGERATE
PART NAME ASSIGNED BY CONTROLLING AGENCYADENOSINE 12 MG, 4 ML SYRINGE, 10S
PHARMACEUTICAL VEHICLE TYPEAQUEOUS
ACTIVE MEDICAMENT MEDICINAL STRENGTH3.0 MILLIGRAMS ADENOSINE ACTIVE INGREDIENT
TOTAL PRIMARY CONTAINER QUANTITY10
OTHER ITEMS IN FSC 6505 — Drugs and Biologicals
Items in the same Federal Supply class. No interchangeability or substitution relationship is implied.
6505-00-000-0073 6505-00-000-0110 6505-00-000-0134 6505-00-000-0135 6505-00-001-3344 6505-00-001-3345 6505-00-001-3346 6505-00-001-3347
SUBSTITUTES & CROSS-REFERENCES 2
1482108Reference document
Same NSN cross-reference
Reference document — Secondary reference
6505NCM173708Reference document
Same NSN cross-reference
Reference document — Secondary reference
LIFECYCLE
NSN statusActive· U.S. Government catalog
Shelf-life managedNo demilitarization required
Ready to buy NDC25021-0301-68?
Compare prices from verified sellers on eBay
Buy on eBay →
As an eBay Partner, PartsTable may earn a commission. Your price is not affected.
FREQUENTLY ASKED QUESTIONS
What is NDC25021-0301-68?
NDC25021-0301-68 is a ADENOSINE INJECTION.
What parts can replace NDC25021-0301-68?
There are 2 known substitutes for NDC25021-0301-68: 1482108, 6505NCM173708. Substitute compatibility should be verified for your specific system.
What is the NSN for NDC25021-0301-68?
NDC25021-0301-68 is cataloged in the U.S. Government catalog under NSN 6505-01-666-0343. This indicates validated use in U.S. government and defense supply chains.
Community Feedback
Leave a Comment
Comments are reviewed before appearing. You will receive an email to verify before your comment appears.

Request a Quote — NDC25021-0301-68